Our company

 > International development

International development

Combino Pharm’s international expansion is based on licensing and supplying drugs to pharmaceutical product laboratories.

Combino Pharm´s fully integrated structure means it can offer the authorisation dossier and supply drugs, ranging from active pharmaceutical ingredients (API), synthesised in the group’s chemical company,Medichem, to finished products, produced at its pharmaceutical plant in Malta.

Combino Pharm also works with properly certified external manufacturers, both in supplying APIs and for the manufacture of some of its medicinal products.

Combino Pharm is committed to the goal of meeting its customers’ needs, offering the company’s full legal and technical know-how and understanding of the regulatory and patent systems, to launch products successfully around the world.

Currently, Combino Pharm exports world-wide, the European Union being its main market.

Imagen 1